A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa

NCT04213261 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Recessive Dystrophic Epidermolysis Bullosa

Interventions

BIOLOGICAL: FCX-007 (dabocemagene autoficel; see below for FCX-007 description)

Sponsor

Castle Creek Biosciences, LLC.